Search results for " Left"

showing 10 items of 417 documents

Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline

2020

Abstract Background Left ventricular ejection fraction (LVEF) trajectories and functional recovery with current heart failure (HF) management is increasingly recognized. Type 2 diabetes mellitus (T2D) leads to a worse prognosis in HF patients. However, it is unknown whether T2D interferes with LVEF trajectories. The aim of this study was to prospectively assess very long-term (up to 15 years) LVEF trajectories in patients with and without T2D and underlying HF. Methods Ambulatory patients admitted to a multidisciplinary HF clinic were prospectively evaluated by scheduled two-dimensional echocardiography at baseline, 1 year, and then every 2 years afterwards, up to 15 years. Statistical anal…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyEjection fractionTime FactorsEtiologyDiabetic CardiomyopathiesEndocrinology Diabetes and MetabolismHeart failureType 2 diabetesVentricular Function LeftVentricular Dysfunction LeftDiabetes mellitusLong-termRisk FactorsInternal medicineDiabetes mellitusDiabetic cardiomyopathymedicineHumansProspective StudiesOriginal InvestigationAngiologyAgedHeart FailureEjection fractionbusiness.industryFollow-upType 2 Diabetes MellitusStroke VolumeMiddle Agedmedicine.diseaseProgression-Free SurvivalDiabetes Mellitus Type 2lcsh:RC666-701Heart failureAmbulatoryDisease ProgressionFemaleCardiology and Cardiovascular Medicinebusiness
researchProduct

Refractory congestive heart failure: when the solution is outside the heart

2020

Abstract Refractory congestive heart failure is associated with an ominous prognosis in which the treatments strategies remain scarce and not well validated. In the last years, continuous ambulatory peritoneal dialysis (CAPD) has emerged as a therapeutic alternative in this subset of patients. So far, it has been associated with a significant improvement in functional capacity and quality of life, together with a striking reduction in the risk of readmissions. We present the case of an elderly patient with severe left ventricular dysfunction and severe mitral and tricuspid regurgitation who presents recurrent admissions for anasarca. After its inclusion in a CAPD programme, the patient expe…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtymedicine.medical_treatmentPeritoneal dialysisCase ReportRegurgitation (circulation)030204 cardiovascular system & hematologyAnasarcaVentricular Function LeftPeritoneal dialysis03 medical and health sciences0302 clinical medicinePeritoneal Dialysis Continuous AmbulatoryQuality of lifeRefractoryInternal medicinemedicineHumans030212 general & internal medicineAgedHeart Failurebusiness.industryContinuous ambulatory peritoneal dialysismedicine.diseaseTricuspid Valve InsufficiencyTreatmentRefractory congestive heart failureEchocardiographylcsh:RC666-701Heart failureQuality of LifeCardiologymedicine.symptomDiureticCardiology and Cardiovascular MedicinebusinessESC Heart Failure
researchProduct

Clinical profile and 1-year clinical outcomes of super elderly patients admitted with acute heart failure

2020

There is scarce information about the clinical profile and prognosis of acute heart failure (AHF) at the extreme ranges of age. We aimed to evaluate the 1-year death (all-cause mortality and HF-death) and HF-rehospitalizations of patients ≥85 years admitted for AHF.We prospectively evaluated a cohort of 3054 patients admitted with AHF from 2007 to 2018 in a third-level center. Age was categorized per 10-year categories (65 years; 65-74 years, 75-84 years, and ≥85 years). The risk of mortality and HF-rehospitalizations across age categories was evaluated with Cox regression analysis and Cox regression adapted for competing events as appropriate.The mean age was 73.6 ± 11.2 years, 48.9% were …

Malemedicine.medical_specialty030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineHumansMedicine030212 general & internal medicineChildAgedAged 80 and overHeart FailureEjection fractionbusiness.industryFemale sexStroke VolumeMean ageMiddle AgedPrognosismedicine.diseaseHospitalizationIncreased riskHeart failureCohortFemalebusinessAll cause mortalityEuropean Journal of Internal Medicine
researchProduct

Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients.

2022

Purpose Only a few studies are available on dose-related effects of sacubitril/valsartan (angiotensin receptor neprilysin inhibition (ARNI)) in real-life patients with heart failure and reduced ejection fraction (HFrEF). We sought to investigate clinical and functional effects in real-life HFrEF patients receiving ARNI at a different cumulative dose. Methods This was an observational study in consecutive outpatients admitted for HFrEF from October 2017 to June 2019. The PARADIGM criteria were needed for enrolment. ARNI was uptitrated according to blood pressure, drug tolerability, renal function and kaliemia. At least 10-month follow-up was required in each patient. Clinical assessment, Kan…

Malemedicine.medical_specialtyARNIBlood PressureWalk TestComorbiditySacubitrilVentricular Function LeftAngiotensin Receptor AntagonistsInternal medicinemedicine6-min walking test Aged Aminobutyrates Angiotensin Receptor Antagonists ARNI Biphenyl Compounds Blood Pressure Comorbidity Dose-Response Relationship Drug Drug Combinations Echocardiography Female Heart failure Humans Left ventricular function Male Middle Aged Prospective Studies Sacubitril/valsartan Stroke Volume Valsartan Ventricular Function Left Walk TestHumansPharmacology (medical)Sacubitril/valsartanProspective Studies6-min walking testAgedPharmacologyHeart FailureEjection fractionDose-Response Relationship DrugCumulative dosebusiness.industryAminobutyratesLeft ventricular functionBiphenyl CompoundsStroke VolumeGeneral MedicineMiddle Agedmedicine.diseaseClinical TrialARNI heart failure left ventricular function 6-minutes walking test Sacubitril/valsartan.Drug CombinationsBlood pressureTolerabilityValsartanEchocardiographyHeart failureCardiologyValsartanFemalebusinessSacubitril Valsartanmedicine.drugEuropean journal of clinical pharmacology
researchProduct

Influence of Comorbid Conditions on One-Year Outcomes in Non–ST-Segment Elevation Acute Coronary Syndrome

2011

To investigate comorbid conditions with prognostic influence in non-ST-segment elevation acute coronary syndrome (NSTEACS).The study group consisted of a derivation cohort of 1017 patients (admitted from October 1, 2002, through October 1, 2008) and an external validation cohort of 652 patients (admitted from February 1, 2006, through September 30, 2009). Comorbid conditions, including risk factors and components of the Charlson comorbidity index (ChCI) and coronary artery disease-specific index, were recorded. The main outcome was one-year mortality.During follow-up, 103 patients died. After adjusting for variables associated with NSTEACS characteristics (base model), 5 comorbid conditions…

Malemedicine.medical_specialtyAcute coronary syndromeMyocardial InfarctionComorbidityRisk AssessmentCoronary artery diseaseVentricular Dysfunction LeftInternal medicinemedicineHumansMyocardial infarctionProspective StudiesAcute Coronary SyndromeAgedAged 80 and overbusiness.industryST elevationMortality rateHazard ratioStroke VolumeGeneral MedicineMiddle Agedmedicine.diseasePrognosisComorbiditySurvival AnalysisConfidence intervalSurgeryMultivariate AnalysisCardiologyOriginal ArticleFemalebusiness
researchProduct

Outcome of extracorporeal membrane oxygenation support for high-risk percutaneous coronary intervention in non-ST-segment elevation acute coronary sy…

2020

Malemedicine.medical_specialtyAcute coronary syndromemedicine.medical_treatmentHemorrhageComorbidityRisk AssessmentSeverity of Illness IndexRussiaVentricular Dysfunction LeftText miningExtracorporeal Membrane OxygenationPercutaneous Coronary InterventionPostoperative Complicationscoronary intervention non-ST-segment elevation acute coronary syndromeInternal medicinemedicineExtracorporeal membrane oxygenationST segmentHumansNon-ST Elevated Myocardial InfarctionAgedbusiness.industryPatient SelectionPercutaneous coronary interventionGeneral Medicinemedicine.diseaseSurvival AnalysisOutcome and Process Assessment Health CareCoronary OcclusionCardiologyextracorporeal membrane oxygenation high-risk percutaneouFemaleRisk AdjustmentCardiology and Cardiovascular MedicinebusinessJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Ventricular dysfunction and number of non compacted segments in non compaction: Non-independent predictors.

2010

Abstract Background Isolated ventricular noncompaction (IVNC) is characterized by multiple prominent trabeculations and deep intertrabecular recesses. Some reports prove that the chronic heart failure may occur in approximately half of the patients. In this report we investigate the correlation between the number of non compacted segments and entity of systolic dysfunction from the registry and subregistries of the SIEC. Method To identify the correlation between ventricular dysfunction and number of segments involved in non compaction we evaluated a consecutive series of 238 patients affected by non compaction, from the SIEC (Societa Italiana di Ecografia Cardiovascolare) registry. The ave…

Malemedicine.medical_specialtyAdolescentCardiomyopathyVentricular non compactionDiastoleCardiomyopathyProminent trabeculationsSeverity of Illness IndexNOVentricular Dysfunction LeftYoung AdultPredictive Value of TestsInternal medicinemedicineHumansRegistriesChildVentricular dysfunctionAgedVentricular non compaction; Cardiomyopathy; Ventricular dysfunction; Number of segments; Compact/spongy ratioAged 80 and overIsolated Noncompaction of the Ventricular Myocardiumbusiness.industryCompact/spongy ratioInfantMiddle Agedmedicine.diseaseNumero signPredictive factorSurgeryHeart failureChild PreschoolCardiologyNumber of segmentsFemaleMyocardial diseaseCardiology and Cardiovascular MedicinebusinessCardiomyopathy; Number of segments Compact/spongy ratio; Ventricular dysfunction; Ventricular non compactionHeart Failure Systolic
researchProduct

Blood pressure and estimated risk of stroke in the elderly population of Spain: the PREV-ICTUS study.

2007

Background and Purpose— The objective of this study was to estimate the high blood pressure values and the 10-year risk of stroke in the Spanish general population aged 60 years or older using the Framingham scale. Methods— This was a multicenter, population-based, cross-sectional study performed in Spanish primary care centers. A randomized selection of centers and recruitment population was used. We collected clinical, biochemical, and electrocardiographic data. Results— We analyzed 7343 subjects (mean age, 71.6 years; standard deviation, 7.0; 53.4% females, 34.4% obese subjects, and 27.1% diabetic subjects). Electrocardiographic–left ventricle hypertrophy was present in 12.9% of the sub…

Malemedicine.medical_specialtyAgingPopulationBlood PressureComorbidityAge DistributionRisk FactorsElderly populationAtrial FibrillationPrevalenceMedicineHumansRisk factoreducationStrokeAgedAdvanced and Specialized Nursingeducation.field_of_studybusiness.industryVascular diseaseMiddle Agedmedicine.diseaseStrokeBlood pressureCross-Sectional StudiesSpainHypertensionPhysical therapyFemaleHypertrophy Left VentricularNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessDemographyStroke
researchProduct

Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.

1999

We investigated the influence of major cardiovascular risk factors (smoking, hypercholesterolemia, diabetes mellitus) on the association between angiotensin-converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphism and echocardiographic left ventricular mass in 225 patients with sustained hypertension, assessed by ambulatory blood pressure monitoring. When the study population was analyzed as a whole, the 3 ACE genotypes did not differ in left ventricular mass (II, 47 g/m2.7; ID, 49 g/m2.7; DD, 51 g/m2.7; p = NS). No difference was found in subjects (n = 135) in whom at least 1 major cardiovascular risk factor was present (II, 51 g/m2.7; ID, 51 g/m2.7; DD: 52 g/m2.7; p = NS). In …

Malemedicine.medical_specialtyAmbulatory blood pressureGenotypeHeart VentriclesPeptidyl-Dipeptidase ALeft ventricular hypertrophyPolymerase Chain ReactionMuscle hypertrophyRisk FactorsInternal medicineDiabetes mellitusmedicineHumansRisk factorAllelesRetrospective StudiesPolymorphism Geneticbiologybusiness.industryAngiotensin-converting enzymeOdds ratioDNABlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseasePrognosisEchocardiography DopplerCardiovascular DiseasesHypertensionCardiologybiology.proteinPopulation studyFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessGene DeletionFollow-Up Studies
researchProduct

Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects

2007

BACKGROUND: Metabolic syndrome (MS) has been associated with an increased left ventricular (LV) mass in recent reports. Little is known about the association of MS with LV mass (LVM) in overweight and obese individuals. The aim of our study was to investigate the relation between MS and LVM in a population of overweight and obese hypertensive subjects. METHODS: 289 non-diabetic essential hypertensives with a body mass index >25 kg/m2, were enrolled. In all subjects routine blood chemistry, echocardiographic examination and 24-h ambulatory blood pressure monitoring were performed. RESULTS: In the group of overweight patients, participants with MS (n=58), when compared to those without it (n=…

Malemedicine.medical_specialtyAmbulatory blood pressurePopulationOverweightEssential hypertensionBody Mass IndexRisk FactorsInternal medicinemedicineHumansObesityeducationmetabolic syndrome left ventricular mass hypertensionMetabolic Syndromeeducation.field_of_studyChi-Square Distributionbusiness.industryBody WeightMiddle AgedOverweightmedicine.diseaseEchocardiography DopplerCross-Sectional StudiesEndocrinologyBlood pressureBlood chemistryHypertensionLinear ModelsCardiologyFemaleHypertrophy Left VentricularMetabolic syndromemedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexInternational Journal of Cardiology
researchProduct